Concepedia

L. Verhagen

LV

6

Publications

1.6K

Citations

6

H-Index

2000

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Rush University Medical Center

Cleveland Clinic

Rush University

University of California, San Francisco

L. Verhagen is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, neurology, and neurodegenerative diseases.

Top concepts

Publications per year

2000–2021

6

Publications

6

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

William J. Marks, Raymond T. Bartus, João Siffert et al. · The Lancet Neurology · 2010 · 669 citations

, , +4

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J. Marks, Jill L. Ostrem, L. Verhagen et al. · The Lancet Neurology · 2008 · 581 citations

, , +4

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

Spiros Konitsiotis, Pierre J. Blanchet, L. Verhagen et al. · Neurology · 2000 · 198 citations

deFOG — A real time system for detection and unfreezing of gait of Parkinson’s patients

Emil Jovanov, Emily Wang, L. Verhagen et al. · 2009 · 98 citations · Full text

, , +20

Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint

Alfons Schnitzler, Pablo Mir, Matthew Brodsky et al. · Neuromodulation Technology at the Neural Interface · 2021 · 62 citations · Full text

Rows per page

1–5 of 6